Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 6837-6843, December 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, C. W.

Internucleosomal Cleavage and Chromosomal Degradation by Bleomycin and Phleomycin in Yeast1

C. W. Moore2

Department of Radiation Biology and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642; and Department of Microbiology, Medical School, and Biochemistry and Biology Graduate Programs, City University of New York, New York, New York 10031

Native chromosomal structure, breakage, and overall degradation were studied following the reaction of whole cells with the anticancer drug bleomycin and structurally related phleomycin. Electrophoretic analyses of cellular DNA established that phleomycin was more reactive with DNA than equimolar bleomycin in the range of 0.67-33 x 10-6 M, produced an optimally visible, though less-extended, oligonucleosomal series at concentrations 12 to 35 times lower than bleomycin, and degraded DNA within nucleosomes. Chromosomes were cleaved into nucleosomes and degraded by phleomycin over substantially narrower dose ranges (1 to 2 x 10-6 M) than by bleomycin (about 1 to 17 x 10-5 M). Bleomycin exhibited higher specificity for internucleosomal cleavage than phleomycin, and trimmed but did not degrade nucleosomes at ≤3 x 10-5 M. Identical nucleosomal repeat sizes (166 ± 3.8 base pairs) were produced by the analogues. The higher reactivity of phleomycin does not result solely from its higher rate of internucleosomal and intranucleosomal chromatin cleavage, since short phleomycin reactions always resulted in more extensive chromatin cleavage than long bleomycin reactions at low concentrations. In vivo (cellular) repair of chromatin damage was comparable (approximately 90% in 1 h) after cells were exposed to low drug concentrations which produced similar numbers of chromatin breaks, and thus also does not account for the higher chromosomal breakage caused by phleomycin than bleomycin at low doses. At high doses, unrepaired breaks are substantially higher after phleomycin treatments than after bleomycin treatments, and thus contribute to the higher lethal effects of phleomycin than bleomycin.

1 This study was supported by the National Institutes of Health (Grant CA25609, Department of Health and Human Services), United Cancer Council, Inc. (Rochester), American Cancer Society, Inc. (IN18; New York, NY), contract DE-AC02-76EVO3490 with the U.S. Department of Energy at the University of Rochester Department of Radiation Biology and Biophysics, and The City University of New York Medical School and City College.

2 To whom requests for reprints should be addressed, at Department of Microbiology, City University of New York Medical School, Science Building, Room 910, Convent Avenue at 138th Street, New York, NY 10031.

Received 1/11/88. Revised 6/29/88. Revised 8/25/88. Accepted 8/31/88.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. Yu, C. Palmer, T. Alenghat, Y. Li, G. Kao, and M. A. Lazar
The corepressor silencing mediator for retinoid and thyroid hormone receptor facilitates cellular recovery from DNA double-strand breaks.
Cancer Res., September 15, 2006; 66(18): 9316 - 9322.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. Wu, D. E. Vanderwall, C. J. Turner, S. Hoehn, J. Chen, J. W. Kozarich, and J. Stubbe
Solution structure of the hydroperoxide of Co(III) phleomycin complexed with d(CCAGGCCTGG)2: evidence for binding by partial intercalation
Nucleic Acids Res., November 15, 2002; 30(22): 4881 - 4891.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Li and M. J. Smerdon
Nucleosome Structure and Repair of N-Methylpurines in the GAL1-10 Genes of Saccharomyces cerevisiae
J. Biol. Chem., November 15, 2002; 277(47): 44651 - 44659.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. W. Moore, J. McKoy, M. Dardalhon, D. Davermann, M. Martinez, and D. Averbeck
DNA Damage-Inducible and RAD52-Independent Repair of DNA Double-Strand Breaks in Saccharomyces cerevisiae
Genetics, March 1, 2000; 154(3): 1085 - 1099.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
S. Wang, C Norbury, A. Harris, and T Toda
Caffeine can override the S-M checkpoint in fission yeast
J. Cell Sci., January 3, 1999; 112(6): 927 - 937.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.